- Home
- NVNI vs ICCM Comparison
NVNI vs ICCM Comparison
Compare NVNI & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NVNI | ICCM |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | Brazil | Israel |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.9M | 45.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NVNI | ICCM |
|---|---|---|
| Price | $3.13 | $0.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 170.3K | ★ 375.3K |
| Earning Date | 09-30-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $31,250,627.00 | $2,975,000.00 |
| Revenue This Year | $12.05 | $13.67 |
| Revenue Next Year | $15.02 | $38.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1491.58 | N/A |
| 52 Week Low | $1.44 | $0.59 |
| 52 Week High | $121.90 | $1.66 |
Technical Indicators
Market Signals| Indicator | NVNI | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 47.32 | 33.27 |
| Support Level | $3.32 | $0.67 |
| Resistance Level | $3.92 | $0.72 |
| Average True Range (ATR) | 0.36 | 0.03 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 23.57 | 12.50 |
Price Performance
Historical ComparisonAbout NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.